✦ LIBER ✦

Incidence and significance of theJAK2V617F mutation in patients with chronic myeloproliferative disorders

✍ Scribed by S. E. Langabeer; F. Ni Ainle; E. Conneally; M. Lawler

Book ID: 107525940
Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 166 KB
Volume: 176
Category: Article
ISSN: 1863-4362
DOI: 10.1007/s11845-007-0026-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of the JAK2-V617F mutation in

Prevalence of the JAK2-V617F mutation in Taiwanese patients with chronic myeloproliferative disorders

✍ C.-H. Lieu; H.-S. Wu; Y.-C. Hon; W.-H. Tsai; C.-F. Yang; C.-C. Wang; Y.-C. Lin; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Analysis of JAK2V617F mutation in Chines

Analysis of JAK2V617F mutation in Chinese patients with myeloproliferative disorders

✍ Suning Chen; Hairong Fei; Ri Zhang; Yongquan Xue; Jinlan Pan; Yafang Wu; Jiannon 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

JAK2V617F mutation in leukaemic transfor

JAK2V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders

✍ Davide Rossi; Clara Deambrogi; Daniela Capello; Michaela Cerri; Monia Lunghi; Gu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB

Incidence of the JAK2 V617F mutation amo

Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders

✍ V. DE STEFANO; A. FIORINI; E. ROSSI; T. ZA; G. FARINA; P. CHIUSOLO; S. SICA; G. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

Correlations of JAK2–V617F mutation with

Correlations of JAK2–V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders

✍ Matthaios Speletas; Eirini Katodritou; Chrisoula Daiou; Eudokia Mandala; Emmanou 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Recently, the acquired mutation JAK2-V617F has been described in the majority of patients with myeloproliferative disorders (MPDs). In this study we evaluated its clinical and laboratory correlates in 166 patients with MPDs. The mutation was detected by allele-specific PCR in 119 patients: 81.4% (35

JAK2V617F mutation and myeloproliferativ

JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis

✍ X. Qi; F. Hu; Z. Yang; G. Han; D. Fan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB